Alli Weight Loss Pills: Side Effects, Dosing and Safety

Quick Answer: Alli weight loss pills contain 60 mg of orlistat, which keeps roughly 25% of the fat in a meal from being absorbed. Over one year, users lost an average of 5.7 pounds (2.6 kg) more than people on diet and exercise alone. The main trade-off is digestive: oily stools, gas with leakage and urgent bowel movements, especially after fatty meals. Rare liver, kidney and pancreas problems have been reported. Pregnancy, breastfeeding, an organ transplant and cyclosporine use rule it out, and the UK label also rules out warfarin.

Alli is one of several medical weight loss options, and it is a modest one. It works best alongside sustainable weight loss habits. It does nothing for fat that is already stored in your body.

What Alli Weight Loss Pills Are and How They Work

Alli is the 60 mg dose of orlistat, sold without a prescription. Orlistat stops part of the fat in a meal from being broken down. That fat then passes out in your stool. It does not touch carbohydrate or protein. The prescription version, Xenical, is a 120 mg dose.

The rules differ between countries. As a result, the same product has different eligibility in the US and the UK.

Sources: Mayo Clinic, UK eMC product information, FDA Xenical label and NHS. Check the box in your country before using it.

How to Take Alli Weight Loss Pills

Take one 60 mg dose with each main meal that contains fat, up to three times a day. In the US, Mayo Clinic advises taking it within an hour of the meal. The UK label allows it before, during or up to an hour after. If you miss a meal or eat no fat, skip that dose.

Fat intake matters. Mayo Clinic suggests keeping fat at or below 30% of calories, or about 15 grams per meal. Eating more fat than that mainly makes the bowel side effects worse. Also see how skipping meals affects weight loss, because a skipped meal means a skipped dose.

Alli Weight Loss Pills Results: What to Expect

Mayo Clinic reports that users lost an average of 5.7 pounds (2.6 kg) more than people on diet and exercise alone over one year. In some studies, over 40% of users lost 5% or more of body weight within a year. Those users also followed a calorie-restricted diet and exercised more. A fair first-month benchmark is about 1 pound (0.5 kg) a week.

However, results vary widely. If you have not lost 5% of your starting weight after a year, Mayo Clinic says stopping is reasonable. The UK label sets a stricter check: review at 12 weeks and stop by 6 months. For a realistic pace, see why losing a pound a day is not realistic.

Why Published Alli Figures Disagree

Two fat-blocking figures circulate. Mayo Clinic gives about 25% for the 60 mg Alli dose. The FDA label gives about 30% for the 120 mg prescription dose. Both are correct for their own dose. Most long trials used the 120 mg dose, so those results do not transfer neatly to Alli.

The four-year XENDOS trial shows the problem. Prescription orlistat produced 5.17% weight loss versus 2.75% with placebo. Its diabetes result was 8.3% cumulative incidence with placebo versus 5.5% with orlistat. Yet the FDA label says the drug did not reduce diabetes risk in people with normal glucose tolerance.

Here is a simple way to size the effect. Suppose a meal holds 15 grams of fat and Alli blocks about a quarter of it. Then roughly 3.75 grams go unabsorbed, which is about 34 calories at 9 calories per gram. Three such meals add up to around 100 calories a day. This is an illustration, not a goal. It shows why the pill is small next to everyday food intake and cannot offset a high-fat diet.

Alli Side Effects: Common and Serious

Common effects come from undigested fat in the bowel. Mayo Clinic lists:

• Oily spotting and gas with oily discharge
• Oily or fatty stools
• Urgent or more frequent bowel movements
• Stomach pain or upset
• Headache, back pain, cold-like symptoms and menstrual changes

Serious problems are rare but need prompt care. Itching, loss of appetite, yellow skin or eyes, light-coloured stools or brown urine can signal liver injury. The FDA’s 2010 review found no confirmed link, yet labels were revised. The UK label also lists hepatitis, with some fatal cases reported.

Severe stomach or back pain that does not settle may mean pancreatitis, and bleeding from the rectum needs review (NHS). Oxalate kidney stones and kidney injury have also been reported. Tell a clinician about severe side or back pain, or blood in the urine. Learn more about kidney failure and its warning signs. Swelling of the lips, tongue or throat, or trouble breathing, needs emergency care.

Alli Drug Interactions and Vitamins

Anyone on these medicines should talk to a pharmacist or prescriber first. If you are on insulin or other diabetes drugs, see also how diabetes medicines affect weight.

Who Should Avoid Alli Weight Loss Pills

Do not use Alli if you are pregnant or breastfeeding, have had an organ transplant, take cyclosporine, or have trouble absorbing food. People at a healthy weight should not use it. The UK label states safety has not been established under age 18, and the US product is for adults 18 and older.

Ask a clinician first if you have had gallbladder problems, kidney stones, pancreatitis or irritable bowel syndrome. Check your BMI and what it can and cannot tell you before assuming you qualify.

Weight-loss pills can reinforce restriction or purging. If you have, or have had, an eating disorder, speak to a clinician before using any weight-loss product. In the US, the National Alliance for Eating Disorders runs a helpline, and you can call or text 988 in a crisis. In the UK, Samaritans is on 116 123.

What the Evidence Says About Alli Claims

Alli Weight Loss Pills FAQ

Related Reading

• Ozempic for weight loss: approval, dose, cost and risks
• Medical weight loss: what it involves
• Sustainable weight loss tips that last
• How to spot a fad diet

Sources

• Mayo Clinic: Alli weight-loss pill, does it work?
• UK eMC: alli 60 mg hard capsules product information (page last updated April 2023)
• FDA: Xenical (orlistat) prescribing information (label version dated 2012)
• NHS: Orlistat, a medicine to treat obesity
• Site pages: sources cited, fact-checking policy and editorial process

Written and fact-checked by the HealthCoachJP editorial team. No clinician has reviewed this article. See our sources cited page. Last reviewed and rewritten October 2026.

Medical disclaimer: this article is general information, not medical advice. Talk to a doctor or pharmacist before starting, stopping or combining any medicine.